Body Weight, Aspirin Dose and Pro-resolving Mediators
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Body Weight
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: This is a two-phase crossover design with run-in and wash out periods prior to each phase.Masking: Double (Participant, Investigator)Primary Purpose: Other
Participation Requirements
- Age
- Between 40 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04697719
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sean Heffron, MD NYU Langone Health